| 摘要 |
Novel compounds of the formula Iin whichR isX is O or S,andR1, R2, R3, R4, R5 and R6 have the meaning indicated in patent claim 1,or a tautomeric ring-closed form, and the (E) isomers and their saltsexhibit endothelin receptor-antagonistic properties. |
